Investigation Into the Antinfluenza Agent Oseltamivir Distributed via the Internet in Japan

Therapeutic Innovation and Regulatory Science

Volumn 47, Issue 6, 2013, Pages 699-705

  Takahashi, Natsumi ^a   Tsuboi, Hirohito ^a   Yoshida, Naoko ^a   Tanimoto, Tsuyoshi ^b   Khan, Mohiuddin Hussain ^a   Kimura, Kazuko ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Antiflu; law; oseltamivir; personal import; Tamiflu

Indexed keywords

ANTIFLU; COUNTERFEIT DRUG; OSELTAMIVIR; UNCLASSIFIED DRUG;

ARTICLE; DRUG COST; DRUG MANUFACTURE; DRUG MARKETING; DRUG PACKAGING; DRUG QUALITY; DRUG SOLUBILITY; HEALTH CARE POLICY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNET; JAPAN; LEGAL ASPECT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEARCH ENGINE;

EID: 84886771746     PISSN: 21684790     EISSN: 21649200     Source Type: Journal    
DOI: 10.1177/2168479013500966     Document Type: Article

References (13)

1. Mackey TK,Liang BA.The global counterfeit drug trade: patient safety and public health risks.J Pharm Sci. 2011;100 (11): 4571-4579.
2. Bate R,Hess K.Assessing website pharmacy drug quality: safer than you think?.PLoS One. 2010;5 (8): e12199.
3. Liang BA,Mackey T.Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.Am J Law Med. 2009;35 (1): 125-184.
4. World Health Organization. Medicines: spurious/falsely-labelled/falsified/counterfeit (SFFC). http://www.who.int/mediacentre/factsheets/fs275/en/. Published May 2012. Accessed February 13, 2013.
5. Inspection and Guidance Division PaMSB, Ministry of Health and Welfare, Japan. Importing or bringing medication into Japan for personal use [in Japanese]. http://www.mhlw.go.jp/topics/0104/tp0401-1.html. Published May 2012. Accessed February 13, 2013.
6. Chief of Pharmaceutical and Medical Safety Bureau MoHaW, Japan. Guidance and control of personal import agencies [in Japanese]. http://www.mhlw.go.jp/kinkyu/diet/tuuchi/0828-4.html. Published August 2002. Accessed February 13, 2013.
7. Pharmaceutical Affairs Law of Japan. Act No. 68, 1960. [in Japanese].
8. Pharmaceutical Affairs Law of Japan. Act No. 11, 1976. [in Japanese].
9. Inspection and Guidance Division PaMSB, Ministry of Health and Welfare, Japan. Comments on private import of anti-influenza virus drug Tamiflu through the web [in Japanese]. http://www.mhlw.go.jp/kinkyu/kenkou/influenza/090520-05.html. Published June 2009. Accessed February 13, 2013.
10. FDA warns about fraudulent Tamiflu. FDA news release June 2010. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm216148.htm. Accessed February 13, 2013.
11. US Pharmacopeia National Formulary 2011: USP 34 NF 29.
12. Order for Enforcement of the Act on Specified Commercial Transactions. Cabinet Order No. 295 of November 24, 1976. [in Japanese].
13. Inspection and Guidance Division PaMSB, Ministry of Health and Welfare, Japan. About the quantity of the medical supplies that an individual is allowed to import without a so-called "Yakkan Shoumei," a kind of import certificate which the Regional Bureau of Health and Welfare issues [in Japanese]. http://www.mhlw.go.jp/topics/0104/tp0401-1.html. Published May 2012. Accessed February 13, 2013.